Review article: faecal calprotectin and histologic remission in ulcerative colitis.
Ferdinando D'AmicoStefanos BonovasSilvio DaneseLaurent Peyrin BirouletPublished in: Alimentary pharmacology & therapeutics (2020)
Faecal calprotectin can be used to predict histologic remission in patients with UC, but the cut-off level varies across studies, according to the test used to measure this biomarker and according to the definition of histologic remission. Larger prospective studies using validated histologic indexes are needed to identify a globally accepted faecal calprotectin cut-off level to discriminate between histologic remission and histologically active disease.